Multivariate Analysis of Demographic and Clinical Characteristics of Diabetes
The goal of type 2 diabetes treatment is to maintain a glycosylated hemoglobin (HbA1c) of < 7%, a goal that has
been made easier through advances in insulin types and delivery options. The Diabetes Control and
Complications Trial showed that patients treated with intensive insulin therapy demonstrated a 3-fold increased
risk of a severe hypoglycemia event, a finding that physicians are aware of, according to Meece.